Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Mast-Cell Sarcoma

1-methyl-3-isobutylxanthine has been researched along with Mast-Cell Sarcoma in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yatsunami, K1
Ichikawa, A1
Tomita, K1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Mast-Cell Sarcoma

ArticleYear
Accumulation of adenosine 3',5'-monophosphate induced by prostaglandin E1 binding to mastocytoma P-815 cells.
    Biochemical pharmacology, 1981, Jun-01, Volume: 30, Issue:11

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Mast-Cell Sarcoma;

1981